In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.
Coins that were created with "nonsense" dies to be used for testing of metal compositions that were supposed to have been destroyed have turned up in a Florida dealer's inventory.